Gerostate Alpha (YC S18)

A pharmaceutical company dedicated to treating aging and age-related disease

Last Funded November 2021

$564,622

raised from 472 investors
Pitch Video
Investor Panel

Highlights

1
šŸ’µ $2.1M raised in initial seed round, at $15M valuation cap
2
šŸ§¬ Team at the forefront of aging research for decades, collectively authoring 200+ papers
3
šŸ’Ŗ Our platform delivers drug candidates to slow aging at a success rate of 20%
4
šŸ­ Funds will be used to test our candidates in aging mice

Featured Investor

Our Team

We know how to stop the threat of chronic disease; and we care because aging is 100% fatal

Pitch

Overview